Is the US prepared to deal with another pandemic or widespread health crisis?

Leans no

Short answer: Better than in 2020 in several concrete ways, but still not where it needs to be—especially on workforce, coordination, stable funding, and global cooperation.

Where the U.S. is stronger now

•Faster medical countermeasures: HHS’s ASPR and BARDA have updated multi‑year plans and budgets to speed vaccines, drugs, diagnostics, and domestic manufacturing; FDA continues to refine emergency pathways. For influenza specifically, BARDA contracts and stockpiles put roughly 10 million H5N1 doses within reach if needed, alongside large antiviral reserves.[1]

•Surveillance upgrades: CDC’s Data Modernization/Public Health Data Strategy and wastewater monitoring (NWSS) have expanded near‑real‑time tracking for SARS‑CoV‑2, H5, RSV, and more; traveler‑based genomic surveillance also caught early signals.[2]

•Healthcare readiness programs: The Hospital Preparedness Program (HPP) and related ASPR cooperative agreements continue to fund health care coalitions; CDC’s PHEP grants back state and local health departments.[3]

•Recent real‑world tests and exercises: H5N1 in U.S. dairy cattle triggered USDA federal orders (testing/reporting, milk surveillance) and interagency response; health facilities have been drilling on detection/isolation for high‑consequence infections.[4]

•Clear legal authorities remain in place: The PREP Act/CICP and FDA’s EUA framework provide liability protections and rapid pathways for countermeasures once an emergency is declared.[5]

What still puts the U.S. at risk

•Fragmented coordination and uneven capabilities: GAO’s 2026 reviews say HHS still needs to better align CDC’s PHEP with ASPR’s HPP and strengthen national diagnostic testing strategy—both critical in the first weeks of an outbreak.[6]

•Public health workforce strain: State and local departments gained temporary COVID‑era staff but many positions were short‑term; vacancies and turnover remain high, risking slower response and communication.[7]

•Supply‑chain and stockpile gaps: The SNS is improved (e.g., new domestic gown procurement), but prior GAO/OIG findings highlight persistent risks if a fast‑moving event creates sudden PPE/diagnostic surges.[8]

•Funding volatility: Wastewater surveillance and other preparedness lines have faced proposed cuts or program changes, which can erode hard‑won capacity between crises.[9]

•Erosion of public trust: Surveys show declining confidence in CDC/FDA/NIH since 2024, which can hinder uptake of guidance and vaccines during emergencies.[10]

•Reduced global coordination: WHO adopted updated International Health Regulations in 2024 and a Pandemic Agreement in 2025, but the U.S. formally withdrew from WHO on January 22, 2026—limiting official channels for joint surveillance, standards, and rapid information‑sharing.[11]

Bottom line

•The U.S. has measurably better tools to see threats earlier and to make/deploy countermeasures faster than before COVID‑19. But preparedness is uneven and brittle where it most matters under stress: coordinated execution across agencies and jurisdictions, a stable frontline workforce, sustained funding, high public trust, and strong ties to global systems. On balance, the country is “more prepared, but not prepared enough.”

If helpful, I can tailor this to your context—for example, what this means for hospitals, schools, or a specific state—and outline concrete steps to improve readiness at that level.

Citations (11)

1aspr.govGovernment
ASPR Releases Five-Year Plan to Strengthen Medical Countermeasure Preparedness | ASPR
Backs: “For influenza specifically, BARDA contracts and stockpiles put roughly 10 million H5N1 doses within reach if needed, alongside large antiviral reserves.”
evidence, article, points to yes. Claim: ASPR and BARDA have multi-year plans and budgets to speed countermeasures, with about 10 million H5N1 doses within reach.
2cdc.govGovernment
About the Public Health Data Strategy | The PHDS | CDC
Backs: “CDC’s Data Modernization/Public Health Data Strategy and wastewater monitoring (NWSS) have expanded near‑real‑time tracking for SARS‑CoV‑2, H5, RSV, and more; traveler‑based genomic surveillance also caught early signals.”
evidence, official document, points to yes. Claim: CDC's Public Health Data Strategy and wastewater monitoring expanded near-real-time surveillance.
3aspr.govGovernment
Hospital Preparedness Program (HPP) | ASPR
Backs: “The Hospital Preparedness Program (HPP) and related ASPR cooperative agreements continue to fund health care coalitions; CDC’s PHEP grants back state and local health departments.”
evidence, reference entry, points to yes. Claim: The Hospital Preparedness Program funds health care coalitions for healthcare readiness.
4azureedge.usLow provenance
Federal Orders | Animal and Plant Health Inspection Service
Backs: “H5N1 in U.S. dairy cattle triggered USDA federal orders (testing/reporting, milk surveillance) and interagency response; health facilities have been drilling on detection/isolation for high‑consequence infections.”
evidence, official document, points to yes. Claim: H5N1 in dairy cattle triggered USDA federal orders for testing, reporting, and milk surveillance.
5thefederalregister.orgLow provenance
12th Amendment to Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19 | 89 FR 99875
Backs: “The PREP Act/CICP and FDA’s EUA framework provide liability protections and rapid pathways for countermeasures once an emergency is declared.”
evidence, official document, points to yes. Claim: The PREP Act and EUA framework provide liability protections and rapid pathways for countermeasures.
6gao.govGovernment
Public Health Preparedness: Improved Coordination Needed for HHS’s Emergency Preparedness Programs | U.S. GAO
Backs: “GAO’s 2026 reviews say HHS still needs to better align CDC’s PHEP with ASPR’s HPP and strengthen national diagnostic testing strategy—both critical in the first weeks of an outbreak.”
evidence, official document, points to no. Claim: GAO says HHS needs to better align CDC's PHEP with ASPR's HPP and strengthen national diagnostic testing strategy.
7naccho.orgNonprofits and think tanks
NACCHO Analysis Shows Local Health Department Workforce Temporarily Rebounded During COVID-19, But Gains Were Uneven and At Risk - NACCHO
Backs: “State and local departments gained temporary COVID‑era staff but many positions were short‑term; vacancies and turnover remain high, risking slower response and communication.”
evidence, article, points to no. Claim: Local health workforce gains were temporary and uneven, with high vacancies and turnover.
8apnews.comNews and mediaquality 1.00
Remember the shortage of medical gowns during COVID? Feds spending $350 million for stockpile
Backs: “The SNS is improved (e.g., new domestic gown procurement), but prior GAO/OIG findings highlight persistent risks if a fast‑moving event creates sudden PPE/diagnostic surges.”
evidence, article, neutral. Claim: The stockpile is improved, with new domestic gown procurement, though supply-chain risks persist.
9apnews.comNews and mediaquality 1.00
CDC studies show value of nationwide wastewater disease surveillance, as potential funding cut looms
Backs: “Wastewater surveillance and other preparedness lines have faced proposed cuts or program changes, which can erode hard‑won capacity between crises.”
evidence, article, points to no. Claim: Wastewater surveillance and other preparedness lines face proposed funding cuts that could erode capacity.
10beckershospitalreview.comNews and mediaquality 0.49
Public confidence in federal health agencies falls for 2nd year: 4 findings
Backs: “Surveys show declining confidence in CDC/FDA/NIH since 2024, which can hinder uptake of guidance and vaccines during emergencies.”
statistic, article, points to no. Claim: Surveys show declining public confidence in CDC, FDA, and NIH, which can hinder uptake of guidance and vaccines.
11who.intGovernment
International health regulations
Backs: “WHO adopted updated International Health Regulations in 2024 and a Pandemic Agreement in 2025, but the U.S. formally withdrew from WHO on January 22, 2026—limiting official channels for joint surveillance, standards, and rapid information‑sharing.”
background, reference entry, points to no. Claim: WHO adopted updated International Health Regulations, but the US withdrawal limits joint surveillance and information-sharing.